Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christel Bruggmann"'
Autor:
Christian Skalafouris, Jean-Luc Reny, Jérôme Stirnemann, Olivier Grosgurin, François Eggimann, Damien Grauser, Daniel Teixeira, Megane Jermini, Christel Bruggmann, Pascal Bonnabry, Bertrand Guignard
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via computerized order entry systems, and clinical pharmacists performing medication reviews as par
Externí odkaz:
https://doaj.org/article/b72f801600ee476382dcf3c5f81de7ff
Autor:
Christel Bruggmann, Julien Adjedj, Sylvain Sardy, Olivier Muller, Pierre Voirol, Farshid Sadeghipour
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 8, p e21938 (2021)
BackgroundSecondary prevention strategies after acute coronary syndrome (ACS) presentation with the use of drug combinations are essential to reduce the recurrence of cardiovascular events. However, lack of drug adherence is known to be common in thi
Externí odkaz:
https://doaj.org/article/1a929c8ed2de493883f352b34a26e15f
Autor:
Christel Bruggmann, Stéphane Fournier, Alice Panchaud, Olivier Muller, Farshid Sadeghipour, Pierre Voirol
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 3334 (2020)
BACKGROUND The European Society of Cardiology recommends beta-blocker prescription after ST-segment elevation myocardial infarction (STEMI). Evidence for beta-blocker indication depends on the presence of left ventricular dysfunction (left ventricul
Externí odkaz:
https://doaj.org/article/13f8d99b257046f5b5927f3d23566f56
Autor:
Farshid Sadeghipour, Zied Ltaief, Mahdieh Astaneh, Christel Bruggmann, Piergiorgio Tozzi, Henri Lu, Pierre Voirol
Publikováno v:
Annals of Pharmacotherapy. 55:830-838
Background Postoperative atrial fibrillation (POAF) is the most common complication occurring after cardiac surgery. Guidelines for the management of this complication are scarce, often resulting in differences in treatment strategy use among patient
Autor:
Jérôme Stirnemann, Pascal Bonnabry, François Eggimann, Christian Skalafouris, Jean-Luc Reny, Olivier Grosgurin, Megane Jermini, Damien Grauser, Daniel Teixeira, Bertrand Guignard, Christel Bruggmann
Publikováno v:
BMC medical informatics and decision making. 22(1)
Background Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via computerized order entry systems, and clinical pharmacists performing medication reviews as part of medi
Autor:
Rachel Fesselet, Pierre Vogt, Christel Bruggmann, Pierre Voirol, Farshid Sadeghipour, Juan F. Iglesias, Marianne Gex-Fabry
Publikováno v:
American Journal of Cardiovascular Drugs
American journal of cardiovascular drugs, vol. 20, no. 1, pp. 105-115
American journal of cardiovascular drugs, vol. 20, no. 1, pp. 105-115
Aim American and European associations of cardiology published specific guidelines about recommended drugs for secondary prevention in ST-segment elevation myocardial infarction (STEMI) patients. Our aim was to assess whether drug prescription for ST
Autor:
Christel Bruggmann, J. Adjedj, Pierre Voirol, Farshid Sadeghipour, Sylvain Sardy, Olivier Muller
Publikováno v:
Journal of Medical Internet Research
Background Secondary prevention strategies after acute coronary syndrome (ACS) presentation with the use of drug combinations are essential to reduce the recurrence of cardiovascular events. However, lack of drug adherence is known to be common in th
Autor:
Christel Bruggmann, Julien Adjedj, Sylvain Sardy, Olivier Muller, Pierre Voirol, Farshid Sadeghipour
BACKGROUND Secondary prevention strategies after acute coronary syndrome (ACS) presentation with the use of drug combinations are essential to reduce the recurrence of cardiovascular events. However, lack of drug adherence is known to be common in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65a915ffb35dc089a16b58c7c7d62772
https://doi.org/10.2196/preprints.21938
https://doi.org/10.2196/preprints.21938
Autor:
Pierre Vogt, Pierre Voirol, Christel Bruggmann, Farshid Sadeghipour, Rachel Fesselet, Juan F. Iglesias
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 52:e16-e17
Background and objectives Adherence to secondary prevention evidence-based medical (EBM) therapies for patients with ST-segment elevation myocardial infarction (STEMI) is essential to reduce long-term rates of major adverse cardiovascular events. Cur